病毒学
表位
抗体
克隆(编程)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
病毒
生物
2019年冠状病毒病(COVID-19)
大流行
计算生物学
医学
免疫学
计算机科学
传染病(医学专业)
疾病
病理
程序设计语言
作者
Yang Dou,Ke Xu,Yong‐Qiang Deng,Zhimin Jia,Jun Lei,Xiaoyu Xu,Guorui Zhang,Tian-Shu Cao,Pan Liu,Xiangxi Wang,Xinquan Wang,Lingjie Xu,Pan Du,Cheng‐Feng Qin,Hong Liu,Yafeng Li,Guizhen Wu,Kang Wang,Lan Bai
摘要
Rapid and efficient strategies are needed to discover neutralizing antibodies (nAbs) from B cells derived from virus-infected patients.Here, we report a high-throughput single-B-cell cloning method for high-throughput isolation of nAbs targeting diverse epitopes on the SARS-CoV-2-RBD (receptor binding domain) from convalescent COVID-19 patients. This method is simple, fast and highly efficient in generating SARS-CoV-2-neutralizing antibodies from COVID-19 patients' B cells.Using this method, we have developed multiple nAbs against distinct SARS-CoV-2-RBD epitopes. CryoEM and crystallography revealed precisely how they bind RBD. In live virus assay, these nAbs are effective in blocking viral entry to the host cells.This simple and efficient method may be useful in developing human therapeutic antibodies for other diseases and next pandemic.
科研通智能强力驱动
Strongly Powered by AbleSci AI